Page last updated: 2024-08-24

gemcitabine and canagliflozin

gemcitabine has been researched along with canagliflozin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ding, J; He, L; Pang, S; Shen, B; Xie, X; Xu, D; Zhou, C; Zhou, Y	1

Other Studies

1 other study(ies) available for gemcitabine and canagliflozin

Article	Year
Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A. International journal of oncology, 2020, Volume: 57, Issue:5 Topics: Animals; Apoptosis; Canagliflozin; Cell Line, Tumor; Deoxycytidine; Down-Regulation; Gemcitabine; Glucose Transporter Type 1; Glycolysis; Humans; Lactate Dehydrogenase 5; Male; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases	2020

Article

Year

Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A.

International journal of oncology, 2020, Volume: 57, Issue:5

Topics: Animals; Apoptosis; Canagliflozin; Cell Line, Tumor; Deoxycytidine; Down-Regulation; Gemcitabine; Glucose Transporter Type 1; Glycolysis; Humans; Lactate Dehydrogenase 5; Male; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2020